首页> 外文期刊>Der Pharmacia Lettre >Preparation and evaluation of pentoxifylline loaded chewable tablet for thetreatment of peripheral vascular diseases
【24h】

Preparation and evaluation of pentoxifylline loaded chewable tablet for thetreatment of peripheral vascular diseases

机译:己酮可可碱咀嚼片治疗周围血管疾病的制备与评价

获取原文
           

摘要

Pentoxifylline, an analogue of theophylline and phosphodiestrase inhibitor is used in the treatment of peripheral vascular diseases. The objective of present investigation was to formulate and in-vitro characterize pentoxifylline loaded chewable tablets for the treatment of peripheral vascular disease with varying concentration of sodium starch glycolate (SSG) as super-disintegrent. The pentoxiphyline loaded chewable tablets were prepared by using wet granulation technique. Lactose and mannitol were used as diluents with different concentration of sodium starch glycolate (SSG) as super-disintegrate The in-vitro drug release profile was carried out in phosphate buffer phosphate buffer saline (PBS pH 6.8) at 37±0.1ºC using USP paddle type II. Prepared granules were subjected to precompression studies like angle of repose and compressibility indices. The compressed formulations were then evaluated for appearance, thickness, weight variation, hardness, friability, drug content uniformity, wetting time and disintegration time and in-vitro drug release profile. The results of all evaluation parameters were within acceptable limits. From the disintegration studies, it was observed that the formulation containing 4.0% w/w of sodium starch glycolate showed minimum disintegration time than other formulations. The optimised formulation showed 97.82% in-vitro drug release in 30 minutes.A significant difference was observed in in-vitro drug release due to varying concentration of superdisintegrant as well as diluents. Thus, it can be concluded that Pentoxifylline loaded chewable tablet can be a potential dosage form for the therapy of peripheral vascular diseases.
机译:己酮可可碱是茶碱和磷酸二酯酶抑制剂的类似物,用于治疗周围血管疾病。本研究的目的是配制和体外表征负载己酮可可碱的咀嚼片,用于治疗周围血管疾病,并以不同浓度的乙醇酸淀粉钠(SSG)作为超级分解剂。通过使用湿法制粒技术制备了载有抗草甘膦的咀嚼片。乳糖和甘露醇用作稀释剂,不同浓度的甘醇淀粉淀粉(SSG)作为超崩解剂。体外药物释放曲线是在37±0.1ºC的磷酸盐缓冲液磷酸盐缓冲盐水(PBS pH 6.8)中使用USP桨叶进行的类型II。将制得的颗粒进行预压缩研究,例如休止角和可压缩性指数。然后评估压缩制剂的外观,厚度,重量变化,硬度,脆性,药物含量均匀性,润湿时间和崩解时间以及体外药物释放曲线。所有评估参数的结果均在可接受的范围内。从崩解研究中观察到,与其他制剂相比,包含4.0%w / w的淀粉羟乙酸钠的制剂显示出最短的崩解时间。优化配方在30分钟内显示97.82%的体外药物释放。由于超崩解剂和稀释剂浓度的变化,在体外药物释放中观察到了显着差异。因此,可以得出结论,载有己酮可可碱的咀嚼片可以是治疗周围血管疾病的潜在剂型。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号